News
System improves chip designs and tackles unsolved maths problems, but has not been rolled out to researchers outside the ...
Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry ...
The artificial intelligence–based structure-prediction software AlphaFold, originally developed by Google DeepMind, has quickly become an important tool for drug discovery. Its original ...
DeepMind partnered with the European Molecular Biology Laboratory (EMBL) to come up with the AlphaFold database, which predicts the three-dimensional structures of the human proteome – nearly ...
T he last time I interviewed Demis Hassabis was back in November 2022, just a few weeks before the release of ChatGPT. Even ...
Artificial intelligence (AI) has long supported pharmaceutical development. The rise of generative AI is now pushing life ...
AlphaFold, the Google DeepMind A.I. system that transformed protein structure prediction, would not have been possible without the Protein Data Bank, a database built on research from NIH-funded ...
The segment revisited DeepMind’s landmark achievement with AlphaFold, the AI model that predicted the structure of over 200 million proteins. Hassabis and colleague John Jumper were awarded the ...
Google DeepMind CEO Demis Hassabis envisions AI eradicating all diseases within a decade, potentially revolutionizing drug design. Hassabis, a Nobel laureate for his work on AlphaFold, believes AI ...
Even then—before the rest of the world went AI-crazy—the CEO of Google DeepMind had a stark warning ... Nobel Prize in Chemistry for his work on Alphafold—an AI system that can predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results